Sources | Names Used |
---|---|
CTRPv2 | navitoclax:pluripotin (1:1 mol/mol) |
PharmacoGx | navitoclax:pluripotin (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | EDEM3 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.02 |
mRNA | HIST2H3C | CTRPv2 | pan-cancer | AAC | -0.085 | 0.02 |
mRNA | DNAAF1 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.02 |
mRNA | MMADHC | CTRPv2 | pan-cancer | AAC | -0.083 | 0.02 |
mRNA | C9orf50 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.02 |
mRNA | PIEZO2 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
mRNA | C1orf27 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.02 |
mRNA | FAM57B | CTRPv2 | pan-cancer | AAC | 0.094 | 0.02 |
mRNA | MAFG | CTRPv2 | pan-cancer | AAC | 0.084 | 0.02 |
mRNA | GLRA2 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.02 |